| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |